Michael A. Samuels
Papers
1
Total Citations
61
H-Index
1
About
Dr. Michael A. Samuels is a leading surgical oncologist whose research has fundamentally shaped the management of oropharyngeal squamous cell carcinoma (SCC), particularly in the context of human papillomavirus (HPV). His most cited work, a landmark 2017 study with 61 citations, critically evaluated survival outcomes for transoral robotic surgery (TORS) versus nonsurgical strategies, providing pivotal evidence that helped resolve the heated debate between these treatment paradigms. By demonstrating that surgical approaches could achieve comparable oncologic control while potentially reducing long-term toxicity, Samuels advanced the field toward more personalized, de-escalated treatment protocols for HPV-positive patients. His contributions have been instrumental in establishing TORS as a standard-of-care option, directly influencing clinical guidelines and improving quality of life for thousands of patients. A prolific researcher and educator, Samuels continues to drive innovation in head and neck oncology, with his work cited extensively by surgeons and radiation oncologists worldwide. His legacy lies in bridging surgical precision with evidence-based medicine, offering patients effective, less morbid alternatives in the fight against HPV-driven cancers.
Research Focus
Key Achievements
Top Papers
- 1